Cytokinetics, Incorporated · NASDAQ:CYTK

Blum Robert I sold 7,500 Cytokinetics, Incorporated shares (Form 4)

Traded Apr 15, 2026 · Filed Apr 15, 2026

On Apr 15, 2026, Blum Robert I (Director, President & CEO) sold 7,500 Cytokinetics, Incorporated shares at US$65.38 for US$490K under a trading plan, leaving 415,330 shares. Filed Apr 15, 2026 (Form 4).

Sold
7,500 shares
Price
US$65.38
Value
US$490K
Holding after
415,330 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, President & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 15, 2026Common StockSale7,500US$65.38415,330Direct

Source

View original at SEC

Related